资源类型：
收录情况：
◇ 统计源期刊
文章类型：
机构：
[1]江西省肿瘤医院药剂科,南昌330029
[2]浙江省杭州市妇产科医院药剂科,杭州310008
[3]云南省曲靖市第一人民医院药剂科,云南曲靖655000
[4]上海交通大学医学院附属瑞金医院呼吸科，上海200025
[5]上海交通大学医学院附属瑞金医院药剂科，上海200025
出处：
ISSN：
关键词：
Clinical pharmacists
Drug treatment regimens
Immunodeficiency
Pneumocytis carinii
Pneumonia
摘要：
Objective: To investigate the drug treatment regimens for critical patients with pneumocytis carinii pneumonia (PCP). Methods: Through direct involvement of clinical pharmacists in the whole drug treatment of 2 immonosuppressed patients, the drug treatment regimens for critical patients with PCP were adjusted, and therapeutic drug efficacy was evaluated and adverse drug reactions were closely monitored in the process. Results: The initial anti-infection treatment of immonosuppressed patients with pulmonary infection should cover PCP. When patients were unable to tolerate high doses of sulfamethodxazole-trimethoprim (SMZ-TMP) or initial treatment with SMZ-TMP was invalid, the combination of SMZ-TMP with caspofungin could be recommended to treat critical PCP. Conclusion: Combination of SMZ-TMP with caspofungin for the treatment of severe PCP had the advantages of faster response, better clinical efficacy, and more importantly, lower incidence of adverse drug reactions. © 2018 Publishing House of Pharmaceutical Care and Research. All rights reserved.
第一作者：
第一作者机构：
[1]江西省肿瘤医院药剂科,南昌330029
通讯作者：
推荐引用方式(GB/T 7714)：
童伟,吴静,黄兴富,等.重症肺囊虫性肺炎的药物治疗方案调整[J].Pharmaceutical Care and Research.2018,18(1):
